Yes most definitely. $ONCS has a very strong pipeline with proven safety and efficacy clinical results. Dan O'Connor's expertise combined with $ONCS EP+IL12 tech should be able to bring BP Partners onboard. Dan will certainly have earned Shareholders respect if he can take $ONCS PPS into the double digits. IMO $ONCS $10, $20, and even $30 PPS are all reachable in 2017/2018